Search

Displaying results 7541 - 7550 of 9313 in total
  1. Drug

    Nitroarginine

    go.drugbank.com/drugs/DB04223
    Investigational

    An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. … Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)

  2. Drug

    Quisqualic acid

    go.drugbank.com/drugs/DB02999
    Experimental

    The compound is obtained from the seeds and fruit of _Quisqualis chinensis_.

  3. Drug

    C31G

    go.drugbank.com/drugs/DB05398
    Investigational

    agent, effective against gram positive and gram negative bacteria, yeast and fungi.C31G, vaginal gel is developed by Biosyn Inc. and has commenced enrollment in a phase III pivotal clinical trial for the

  4. Drug

    Ceramide NP

    go.drugbank.com/drugs/DB14111
    Investigational

    Ceramides are major lipid components in the stratum corneum of the human skin. Ceramide 3 consists of a phytosphingosine backbone N-acylated with a saturated fatty acid (stearic acid) [A27233]. … Together with ceramide 1, they synergistically improve the skin barrier function in humans [A27232, A27233].

  5. Drug

    Amodiaquine

    go.drugbank.com/drugs/DB00613
    ApprovedInvestigational

    A 4-aminoquinoquinoline compound with anti-inflammatory properties.

  6. Drug

    NVS antibody

    go.drugbank.com/drugs/DB05312
    Experimental

    This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.

  7. Drug

    3-hydroxyanthranilic acid

    go.drugbank.com/drugs/DB03644
    Experimental

    It may be a free radical scavenger and a carcinogen.

  8. Drug

    Pavinetant

    go.drugbank.com/drugs/DB11692
    Investigational

    Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.

  9. Drug

    Mitoglitazone

    go.drugbank.com/drugs/DB11721
    Investigational

    Mitoglitazone has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.

  10. Drug

    DS-2325a

    go.drugbank.com/drugs/DB18134
    Investigational

    DS-2325a is an inhibitor of kallikrein 5 under development for the treatment of Netherton Syndrome.